ATHENEX INC. | 0.476 / -6.08% |
Date/Time | 08/17 / 21:17 |
Chg. / Chg.(%) | -0.031 / -6.08% |
Bid | 0.481 / 5000 |
Ask | 0.508 / 5000 |
Open | 0.499 |
Previous Close | 0.507 |
High | 0.499 |
Low | 0.474 |
Volume [EUR] | 0.000 |
Volume [Units] | 0 |
Price fixings | 8 |
ISIN | US04685N1037 |
Security | 2MT |
Exchange | Stuttgart |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 0.489 | ![]() |
|
NASDAQ | 0.5000 | ![]() |
3,417,301 |
Cboe US | 0.50 | ![]() |
96,337 |
IEX | 0.50 | ![]() |
19,931 |
TradeGate | 0.49 | ![]() |
12,390 |
gettex | 0.5105 | ![]() |
266 |
Frankfurt | 0.5012 | ![]() |
0 |
Stuttgart | 0.476 | ![]() |
0 |
München | 0.524 | ![]() |
0 |
Berlin | 0.484 | ![]() |
0 |
Düsseldorf | 0.480 | ![]() |
0 |
Quotrix | 0.5115 | ![]() |
News
- Athenex Provides Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
03/16/2022 / 21:10 - GlobeNewswire - Athenex to Provide Corporate and Financial Update for the Fourth Quarter and Full Year 2021, on March 15, 2022
03/07/2022 / 14:00 - GlobeNewswire - Athenex Announces Appointment of Chief Financial Officer
02/22/2022 / 14:00 - GlobeNewswire - Athenex to Present at the 11th Annual SVB Leerink Global Healthcare Conference
02/09/2022 / 14:00 - GlobeNewswire - Athenex Announces UK MHRA Validation of the Marketing Authorization Application for Oral Paclitaxel and Encequidar for Review
11/29/2021 / 14:00 - GlobeNewswire